Amazon scraps secret fertility-tracking project
Amazon discontinued its secret "Encore" project, a fertility monitoring device and app, originating from its 2020 acquisition of bluDiagnostics.
MAIN POINTS
- Amazon's "Encore" project focused on fertility monitoring technology.
- The project was initiated after acquiring bluDiagnostics in 2020.
- The device measured estradiol and progesterone levels.
- CNBC reported the shutdown of this four-year-old program.
TAKEAWAYS
- Amazon continues to explore and occasionally discontinue health-related technology projects.
- Acquisitions can lead to new product development, as seen with bluDiagnostics.
- Fertility monitoring remains a complex and competitive field.
- Strategic decisions can lead to the termination of long-term projects.